cbdMD (YCBD) EBIAT (2016 - 2025)
cbdMD's EBIAT history spans 10 years, with the latest figure at -$283131.0 for Q4 2025.
- For Q4 2025, EBIAT fell 1975.66% year-over-year to -$283131.0; the TTM value through Dec 2025 reached -$2.3 million, up 13.0%, while the annual FY2025 figure was -$2.0 million, 44.84% up from the prior year.
- EBIAT for Q4 2025 was -$283131.0 at cbdMD, up from -$679902.0 in the prior quarter.
- Across five years, EBIAT topped out at $1.5 million in Q2 2021 and bottomed at -$31.6 million in Q2 2022.
- The 5-year median for EBIAT is -$1.6 million (2023), against an average of -$5.7 million.
- The largest annual shift saw EBIAT crashed 2157.79% in 2022 before it skyrocketed 125.97% in 2024.
- A 5-year view of EBIAT shows it stood at -$19.2 million in 2021, then skyrocketed by 79.35% to -$4.0 million in 2022, then skyrocketed by 74.81% to -$996501.0 in 2023, then surged by 101.51% to $15095.0 in 2024, then crashed by 1975.66% to -$283131.0 in 2025.
- Per Business Quant, the three most recent readings for YCBD's EBIAT are -$283131.0 (Q4 2025), -$679902.0 (Q3 2025), and -$895338.0 (Q2 2025).